The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pharmanutra SpA
MIL:PHN
|
IT |
|
J
|
Jiangsu Financial Leasing Co Ltd
SSE:600901
|
CN |
|
D
|
Danaher Corp
DUS:DAP
|
US |
|
M
|
Murphy Oil Corp
XMUN:MUQ
|
US |
|
N
|
Nucor Corp
XMUN:NUO
|
US |
|
A
|
Aston Martin Lagonda Global Holdings PLC
OTC:ARGGY
|
UK |
|
Schneider Electric SE
PAR:SU
|
FR |
|
ING Groep NV
AEX:INGA
|
NL |
|
H
|
Heidelberg Materials AG
DUS:HEI
|
DE |
|
Intesa Sanpaolo SpA
MIL:ISP
|
IT |
|
G
|
Glencore PLC
F:8GC
|
CH |
|
Hilton Worldwide Holdings Inc
NASDAQ:HLT
|
US |
|
A
|
Applied Materials Inc
F:AP2
|
US |
|
Condor Energies Inc
F:WQ6
|
CA |
|
C
|
Citigroup Inc
XMUN:TRVC
|
US |
|
U
|
United Internet AG
XMUN:UTDI
|
DE |
|
W
|
Walmart Inc
DUS:WMT
|
US |
|
S
|
Sega Sammy Holdings Inc
OTC:SGAMF
|
JP |
|
O
|
O'Reilly Automotive Inc
F:OM6
|
US |
|
China Mobile Ltd
F:CTM
|
CN |
|
C
|
Citigroup Inc
XHAM:TRVC
|
US |
|
Shinkin Central Bank
TSE:8421
|
JP |
|
E
|
Equifax Inc
DUS:EFX
|
US |
|
EPR Properties
F:E2H
|
US |
Pharmanutra SpA (PHN)’s 12-month stock price forecast through November 2027 has a consensus target of €94.86, implying 29% upside. The forecast is based on price targets from 4 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
PHN is 94.86 EUR with a low forecast of 92.92 EUR and a high forecast of 107.1 EUR.
Over the last 9 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 8 years is 9%.
Over the last 9 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 3 years is 16%.
Over the last 9 years, the compound annual growth rate for Operating Income has been 19%. The projected CAGR for the next 8 years is 9%.
Over the last 9 years, the compound annual growth rate for Pre-Tax Income has been 20%. The projected CAGR for the next 3 years is 20%.
Over the last 9 years, the compound annual growth rate for Net Income has been 20%. The projected CAGR for the next 3 years is 22%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more